EPZ004777 |
EPZ004777 : SAM competitive inhibitor of DOT1L
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| DOT1L |
|
|
SAM competitive
1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
EPZ004777 is >1,000-fold selective for DOT1L over other PMTs tested (CARM1, EHMT2, EZH1, EZH2, PRMT1 ...
Selectivity Assessment Description:
Not available
In Cell Selectivity Assessment
Potency Assay Off-Target:
PRMT5 (H4R3), PRDMs ((H3K9) and SMYDs (H3K4) protein substrates were not impacted in cells.
Selectivity Assessment Description:
Not available
Potency Cellular
In Vitro
DOT1L
Mode of Action: SAM competitive
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1016/j.ccr.2011.06.009
In Vivo Validations
Mouse
Dose: 50 mg/mL continuous infusion
Route of delivery:
Subcutaneous
Organ of interest (O):
MV4-11 xenograft
Target engagement assay:
Indirect, decrease in substrate methylation in the tumor.
Authors noted that EPZ004777 had a poor PK profile, which necessitated delivery by continuous infusion.
DOI Reference: 10.1016/j.ccr.2011.06.009
Chemical Information
| Molecular Formula | C28H41N7O4 |
| SMILEs | CC(C)N(CCCNC(=O)Nc1ccc(C(C)(C)C)cc1)C[C@H]1O[C@@H](n2ccc3c(N)ncnc32)[C@H](O)[C@@H]1O |
| InChI | InChI=1S/C28H41N7O4/c1-17(2)34(13-6-12-30-27(38)33-19-9-7-18(8-10-19)28(3,4)5)15-21-22(36)23(37)26(39-21)35-14-11-20-24(29)31-16-32-25(20)35/h7-11,14,16-17,21-23,26,36-37H,6,12-13,15H2,1-5H3,(H2,29,31,32)(H2,30,33,38)/t21-,22-,23-,26-/m1/s1 |
| Molecular weight | 539.32 Da |
| AlogP | 2.8524 |
| HBond acceptors | 11 |
| HBond donors | 6 |
| Atoms | 80 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.